New: Mobile-mode and night-mode!

Are you a harm reduction organisation using TripSit? Let us know about you!
Notice something wrong with this page? Let us know!

1B-LSD

Basic Information

Summary

1B-LSD (1-butanoyl-lysergic acid diethylamide) is an LSD analogue which appears to be about as potent as 1P-LSD (slightly more potent than LSD) and has a slightly shorter duration than that of LSD, again thought to be about the same as 1P-LSD. Released in late 2018, and marketed agressively as a replacement for 1P-LSD. 1B-LSD does not yet have a clearly established safety profile,

Tentative

Drugs marked as tentative are those our team wasn't able to find much reliable information about. This is often because the drug is very new. Information listed under these drugs should not be entirely trusted.

Research Chemical

Research chemicals are drugs with relatively little history of human use, and thus particular care should be taken if choosing to ingest them.

Read more on TripSit Wiki...

Psychedelic

Psychedelics are drugs which alter the perception, causing a number of mental effects which manifest in many forms including altered states of consciousness, visual or tactile effects.

Read more on TripSit Wiki...

Dose

Oral
Light25-50ug
Common50-125ug
Strong125-250ug

NOTE: At the time of this chemical's release, the manufacturers claimed 1B-LSD was expected to be slightly less potent than 1P-LSD, supposedly owing to the increased mass of the butanoyl group over the propionyl group, however anecdotes seem to indicate approximate equipotency to 1P-LSD.

Duration

All ROAs
Onset45-90 minutes
Duration8-12 hours
After-effects6-24 hours

Aliases

1b

See TripSit Wiki for more information about drug interactions

Interactions

No interaction information for 1B-LSD